Key regions: Australia, China, United Kingdom, Canada, United States
The Sleep Aids market in G20 countries is experiencing significant growth due to changing customer preferences, emerging trends, and local special circumstances.
Customer preferences: Customers in G20 countries are increasingly prioritizing their sleep health and seeking solutions to improve their sleep quality. Factors such as high stress levels, longer working hours, and the prevalence of digital devices have contributed to a growing demand for sleep aids. Consumers are looking for products that can help them fall asleep faster, stay asleep longer, and wake up feeling refreshed. They are also showing a preference for natural and non-habit forming sleep aids.
Trends in the market: One of the key trends in the Sleep Aids market in G20 countries is the shift towards natural and herbal sleep aids. Customers are becoming more conscious about the potential side effects of pharmaceutical sleep aids and are seeking safer alternatives. This has led to the rise of products containing ingredients such as melatonin, valerian root, and chamomile, which are known for their sleep-promoting properties.Another trend in the market is the increasing availability of sleep aids in different formats. While traditional sleep aids such as pills and capsules remain popular, customers are also exploring alternative formats such as gummies, teas, and sprays. This allows them to choose a format that suits their preferences and lifestyle.
Local special circumstances: The Sleep Aids market in G20 countries is influenced by various local special circumstances. For example, in countries with high levels of stress and long working hours, such as Japan and South Korea, there is a higher demand for sleep aids to help people relax and improve their sleep quality. In countries with aging populations, such as Germany and Italy, there is a growing market for sleep aids targeting age-related sleep disorders.
Underlying macroeconomic factors: The Sleep Aids market in G20 countries is also influenced by underlying macroeconomic factors. Rising disposable incomes, urbanization, and increasing awareness about sleep health are driving the growth of the market. As people have more disposable income, they are willing to invest in products that can improve their sleep quality. Urbanization and busy lifestyles have also contributed to sleep disturbances, leading to a higher demand for sleep aids.In conclusion, the Sleep Aids market in G20 countries is witnessing growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. As customers prioritize their sleep health and seek solutions to improve their sleep quality, the market is responding with a range of natural and alternative sleep aids. The market is expected to continue growing as awareness about sleep health increases and disposable incomes rise.
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
